Balancing Risk and Reward: Greater Research Oversight Is Appropriate for Novel Therapies for Children With Life-Limiting Illness
- PMID: 32223620
- DOI: 10.1080/15265161.2020.1730484
Balancing Risk and Reward: Greater Research Oversight Is Appropriate for Novel Therapies for Children With Life-Limiting Illness
Comment on
-
Greater Than Minimal Risk, No Direct Benefit - Bridging Drug Trials and Novel Therapy in Pediatric Populations.Am J Bioeth. 2020 May;20(4):102-103. doi: 10.1080/15265161.2020.1730488. Am J Bioeth. 2020. PMID: 32208073 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources